In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system

This publication has 31 references indexed in Scilit:

• Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease
  Gene Therapy, 2004
• Heparin Coinfusion during Convection-Enhanced Delivery (CED) Increases the Distribution of the Glial-Derived Neurotrophic Factor (GDNF) Ligand Family in Rat Striatum and Enhances the Pharmacological Activity of Neurturin
  Experimental Neurology, 2001
• Acute Direct Adenoviral Vector Cytotoxicity and Chronic, but Not Acute, Inflammatory Responses Correlate with Decreased Vector-Mediated Transgene Expression in the Brain
  Molecular Therapy, 2001
• High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy
  Human Gene Therapy, 1999
• Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus
  Gene Therapy, 1999
• Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions
  Synapse, 1999
• Behavioral and Cellular Protection of Rat Dopaminergic Neurons by an Adenoviral Vector Encoding Glial Cell Line-Derived Neurotrophic Factor
  Experimental Neurology, 1998
• Recombinant Adenovirus: A Gene Transfer Vector for Study and Treatment of CNS Diseases
  Experimental Neurology, 1997
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
  Science, 1997
• Immune responses to adenovirus vectors in the nervous system
  Trends in Neurosciences, 1996